Search research articles
Contact Us
Filters
Showing results (131-140 of 147) with videos related to
Page
of 15
Sort By:
The Journal of Biological Chemistry
|
August 24, 2005
F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers
Olga M Hernandez, Danuta Szczesna-Cordary, Björn C Knollmann, et al.
The Journal of Biological Chemistry
|
November 6, 2007
Triadins modulate intracellular Ca(2+) homeostasis but are not essential for excitation-contraction coupling in skeletal muscle
Xiaohua Shen, Clara Franzini-Armstrong, Jose R Lopez, et al.
Journal of Medicinal Chemistry
|
March 21, 2003
Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase
Li Sun, Chris Liang, Sheri Shirazian, et al.
Ebiomedicine
|
December 7, 2023
CD248 promotes insulin resistance by binding to the insulin receptor and dampening its insulin-induced autophosphorylation
Patricia O Benedet, Nooshin S Safikhan, Maria J Pereira, et al.
Nature Communications
|
November 14, 2022
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance
Dhivya Sridaran, Surbhi Chouhan, Kiran Mahajan, et al.
Biochemistry
|
August 14, 2015
Diacyltransferase Activity and Chain Length Specificity of Mycobacterium tuberculosis PapA5 in the Synthesis of Alkyl β-Diol Lipids
Megan H Touchette, Gopal R Bommineni, Richard J Delle Bovi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship
Dirk B Mendel, A Douglas Laird, Xiaohua Xin, et al.
Journal of Great Lakes Research
|
July 24, 2018
Ecosystem services in the Great Lakes
Alan D Steinman, Bradley J Cardinale, Wayne R Munns, et al.
Elife
|
November 21, 2024
ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis
Stephanie Guillet, Tomi Lazarov, Natasha Jordan, et al.
Elife
|
March 14, 2025
A microglia clonal inflammatory disorder in Alzheimer's disease
Rocio Vicario, Stamatina Fragkogianni, Leslie Weber, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 147) with videos related to
Sort By:
Page
of 15
The Journal of Biological Chemistry
|
August 24, 2005
F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers
Olga M Hernandez, Danuta Szczesna-Cordary, Björn C Knollmann, et al.
The Journal of Biological Chemistry
|
November 6, 2007
Triadins modulate intracellular Ca(2+) homeostasis but are not essential for excitation-contraction coupling in skeletal muscle
Xiaohua Shen, Clara Franzini-Armstrong, Jose R Lopez, et al.
Journal of Medicinal Chemistry
|
March 21, 2003
Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase
Li Sun, Chris Liang, Sheri Shirazian, et al.
Ebiomedicine
|
December 7, 2023
CD248 promotes insulin resistance by binding to the insulin receptor and dampening its insulin-induced autophosphorylation
Patricia O Benedet, Nooshin S Safikhan, Maria J Pereira, et al.
Nature Communications
|
November 14, 2022
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance
Dhivya Sridaran, Surbhi Chouhan, Kiran Mahajan, et al.
Biochemistry
|
August 14, 2015
Diacyltransferase Activity and Chain Length Specificity of Mycobacterium tuberculosis PapA5 in the Synthesis of Alkyl β-Diol Lipids
Megan H Touchette, Gopal R Bommineni, Richard J Delle Bovi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2003
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship
Dirk B Mendel, A Douglas Laird, Xiaohua Xin, et al.
Journal of Great Lakes Research
|
July 24, 2018
Ecosystem services in the Great Lakes
Alan D Steinman, Bradley J Cardinale, Wayne R Munns, et al.
Elife
|
November 21, 2024
ACK1 and BRK non-receptor tyrosine kinase deficiencies are associated with familial systemic lupus and involved in efferocytosis
Stephanie Guillet, Tomi Lazarov, Natasha Jordan, et al.
Elife
|
March 14, 2025
A microglia clonal inflammatory disorder in Alzheimer's disease
Rocio Vicario, Stamatina Fragkogianni, Leslie Weber, et al.
Page
of 15